Morning Market Losers

(NASDAQ:

) shares declined 49.03 percent to $4.20 after the company reported top line results from GS-4774 Phase 2 trial in virally-suppressed chronic HBV patients.

(NYSE:

) shares dipped 18.70 percent to $49.26 after the company reported weaker-than-expected earnings for the fiscal fourth quarter and issued a downbeat forecast for the current quarter.

(NASDAQ:

) shares fell 10.93 percent to $16.58. 21Vianet Group reported a Q1 loss of $0.22 per share on revenue of $138.7 million.

(NYSE:

) shares dropped 9.09 percent to $84.08 on Q1 results. Workday posted a Q1 a non-GAAP net loss of $0.02 per share, versus a non-GAAP net loss of $0.13 per share. Its total revenue climbed 57 percent year-over-year to $251.0 million.

(NASDAQ:

) shares fell 8.14 percent to $2.03. MOL reported a Q1 loss of $0.08 per share on revenue of $15.458 million.

(NASDAQ:

) shares slipped 4.01 percent to $3.35 after jumping 15.95 percent on Tuesday.

(NASDAQ:

) shares tumbled 3.18 percent to $4.57 as the company withdrew its 2015 outlook due to general reimbursement uncertainty.

(NASDAQ:

) shares fell 1.48 percent to $44.49 after the company reported a $600 million convertible notes offering.